Related Experiment Video
Updated: Apr 20, 2026
06:52
Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
1.9K
Randomized, controlled trial in groups C and D retinoblastoma
Rachna Meel1, Sameer Bakhshi2, Neelam Pushker1
1Oculoplastics & Ocular Oncology Service, All India Institute of Medical Sciences, New Delhi, India; Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Ophthalmology
|December 3, 2014
Summary
No abstract available in PubMed .
Related Concept Videos
01:20The Retinoblastoma Gene
5.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
01:20The Retinoblastoma Gene
2.9K
2.9K
01:11Blinding
4.2K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.2K